Papers: 6 May 2013 - 13 May 2013 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity. Marignier R, Bernard-Valnet R, Giraudon P, Collongues N, Papeix C, Zéphir H, Cavillon G, Rogemond V, Casey R, Frangoulis B, et al. Neurology. 2013 May 8. PMID: 23658379. Abstract Editors' Pick Incidence of multiple sclerosis in multiple racial and ethnic groups. Langer-Gould A, Brara SM, Beaber BE, Zhang JL Neurology. 2013 May 7; 80(19):1734-9. Epub 1969 Dec 31. PMID: 23650231. Abstract Editors' Pick Activated microglia enhance neurogenesis via trypsinogen secretion. Nikolakopoulou AM, Dutta R, Chen Z, Miller RH, Trapp BD Proc Natl Acad Sci U S A. 2013 May 6. PMID: 23650361. Abstract Editors' Pick Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Rafalski VA, Ho PP, Brett JO, Ucar D, Dugas JC, Pollina EA, Chow LML, Ibrahim A, Baker SJ, Barres BA, et al. Nat Cell Biol. 2013 May 5; 15(6):614-624. Epub 2013 May 05. PMID: 23644469. Abstract Coenzyme Q10 Supplementation Reduces Oxidative Stress and Increases Antioxidant Enzyme Activity in Patients with Relapsing-Remitting Multiple Sclerosis. Sanoobar M, Eghtesadi S, Azimi A R, Khalili M, Jazayeri S, Gohari M R Int J Neurosci. 2013 May 10. PMID: 23659338. Abstract Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis. Bouafia A, Golmard J-L, Thuries V, Sazdovitch V, Duyckaerts C, Hauw JJ, Fontaine B, Seilhean D Neuropathol Appl Neurobiol. 2013 May 10. PMID: 23659577. Abstract Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis. Nielsen N M, Jørgensen KT, Bager P, Stenager E, Pedersen BV, Hjalgrim H, Koch-Henriksen N, Frisch M Am J Epidemiol. 2013 May 9. PMID: 23660795. Abstract Pertussis toxin attenuates experimental autoimmune encephalomyelitis by upregulating neuronal vascular endothelial growth factor. Tang Z, Yin J-X, Han P, Gan Y, Coons SW, Wang C, Maalouf M, Shi J Neuroreport. 2013 Jun 19; 24(9):469-75. PMID: 23660634. Abstract Multiple sclerosis lymphocytes upregulate A2A adenosine receptors which are anti-inflammatory when stimulated. Vincenzi F, Corciulo C, Targa M, Merighi S, Gessi S, Casetta I, Gentile M, Granieri E, Borea P A, Varani K Eur J Immunol. 2013 May 10. PMID: 23661562. Abstract Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges. Fujihara K, Leite M I Neurology. 2013 May 8. PMID: 23658387. Abstract CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: No. Tur C, Montalban X Mult Scler. 2013 May; 19(6):717-8. PMID: 23658236. Abstract CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: Commentary. Hutchinson M Mult Scler. 2013 May; 19(6):719-20. PMID: 23658237. Abstract Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores. Zagaglia S, Balestrini S, Perticaroli E, Danni MC, Luzzi S, Silvestrini M, Provinciali L Neurol Sci. 2013 May 10. Epub 2013 May 10. PMID: 23660636. Abstract The Immune Pathogenesis of Multiple Sclerosis. Weissert R J Neuroimmune Pharmacol. 2013 May 10. Epub 2013 May 10. PMID: 23660832. Abstract Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival. Medina-Rodríguez EM, Arenzana FJ, Pastor J, Redondo M, Palomo V, García de Sola R, Gil C, Martínez A, Bribián A, de Castro F Cell Mol Life Sci. 2013 May 10. Epub 2013 May 10. PMID: 23661015. Abstract Editorial comment. Mult Scler. 2013 May; 19(6):825. PMID: 23658238. Abstract Induction Therapy for Patients with Multiple Sclerosis: Why? When? How? Edan G, Lepage E CNS Drugs. 2013 May 9. PMID: 23657788. Abstract Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5. Rahgozar K, Wright E, Carrithers LM, Carrithers MD J Neuropathol Exp Neurol. 2013 Jun; 72(6):489-504. PMID: 23656992. Abstract Multiple sclerosis: autoimmunity and viruses. Cusick MF, Libbey JE, Fujinami RS Curr Opin Rheumatol. 2013 May 7. PMID: 23656710. Abstract Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells. Møller-Larsen A, Brudek T, Petersen T, Petersen E L, Aagaard M, Hansen D T, Christensen T Clin Exp Immunol. 2013 May 9. PMID: 23656307. Abstract Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes. Sandberg-Wollheim M, Olsson T Mult Scler. 2013 May; 19(6):714-6. PMID: 23658235. Abstract Evoked potential tests in clinical diagnosis. Sand T, Kvaløy M B, Wader T, Hovdal H Tidsskr Nor Laegeforen. 2013 May 7; 133(9):960-965. PMID: 23652144. Abstract Demographic and clinical factors associated with changes in employment in multiple sclerosis. Moore P, Harding KE, Clarkson H, Pickersgill TP, Wardle M, Robertson NP Mult Scler. 2013 May 7. PMID: 23652213. Abstract High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study. Tinghög P, Hillert J, Kjeldgård L, Wiberg M, Glaser A, Alexanderson K Mult Scler. 2013 May 7. PMID: 23652218. Abstract Clinical impact of early brain atrophy in clinically isolated syndromes. Pérez-Miralles F, Sastre-Garriga J, Tintoré M, Arrambide G, Nos C, Perkal H, Río J, Edo M, Horga A, Castilló J, et al. Mult Scler. 2013 May 7. PMID: 23652215. Abstract Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis. Lapshin H, Lanctôt KL, O'Connor P, Feinstein A Mult Scler. 2013 May 7. PMID: 23652217. Abstract The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study. Lacy M, Hauser M, Pliskin N, Assuras S, Valentine MO, Reder A Mult Scler. 2013 May 7. PMID: 23652214. Abstract The economic impact of multiple sclerosis in Australia in 2010. Palmer AJ, Colman S, O'Leary B, Taylor BV, Simmons RD Mult Scler. 2013 May 7. PMID: 23652216. Abstract Elevated CSF histamine levels in multiple sclerosis patients. Kallweit U, Aritake K, Bassetti CL, Blumenthal S, Hayaishi O, Linnebank M, Baumann CR, Urade Y Fluids Barriers CNS. 2013 May 9; 10(1):19. Epub 2013 May 09. PMID: 23659456. Abstract Clinical and pathological features of acute optic neuritis in Chinese patients. Zhang J-Y, Shen X-Z, Sun L, Lu Z-Z, Ye W Chin Med J (Engl). 2013 May; 126(9):1689-92. PMID: 23652052. Abstract Upregulation of ciliary neurotrophic factor in astrocytes by aspirin: Implications for remyelination in multiple sclerosis. Modi KK, Sendtner M, Pahan K J Biol Chem. 2013 May 7. PMID: 23653362. Abstract A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis. Yusuf A, Koski L J Neurol Sci. 2013 May 4. PMID: 23651867. Abstract The perceptions of people with multiple sclerosis about the NHS provision of physiotherapy services. Markwick R, Singleton C, Conduit J Disabil Rehabil. 2013 May 7. PMID: 23651127. Abstract Month of birth in multiple sclerosis with and without longitudinally extensive spinal cord lesions: A study of a Japanese national survey. Araki Y, Kinoshita M, Motoyama R, Matsushita T, Nakagawa M, Kira J-I, Tanaka M J Neurol Sci. 2013 May 4. PMID: 23651868. Abstract Metallic gold beads in hyaluronic acid: a novel form of gold-based immunosuppression? Investigations of the immunosuppressive effects of metallic gold on cultured J774 macrophages and on neuronal gene expression in experimental autoimmune encephalomyeliti Pedersen D S, Tran T P, Smidt K, Bibby B M, Rungby J, Larsen A Biometals. 2013 May 8. Epub 2013 May 08. PMID: 23653168. Abstract Adherence Associated with Oral Medications in the Treatment of Spasticity. Halpern R, Gillard P, Graham GD, Varon SF, Zorowitz RD PM R. 2013 May 3. PMID: 23648652. Abstract Tadeusz Markiewicz - the researcher's profile and his role in the studies on neuromyelitis optica. Michalak S Neurol Neurochir Pol. 2013; 47(2):194-198. PMID: 23650011. Abstract Effects of whole-body vibration training on physical function in patients with Multiple Sclerosis. Hilgers C, Mündermann A, Riehle H, Dettmers C NeuroRehabilitation. 2013 Jan 1; 32(3):655-63. PMID: 23648620. Abstract Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. Tanaka T, Murakami K, Bando Y, Yoshida S J Neurochem. 2013 May 7. PMID: 23647102. Abstract Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Gelfand JM, Green AJ Brain. 2013 Feb 8. PMID: 23650224. Abstract Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers. Parisé H, Laliberté F, Lefebvre P, Duh M S, Kim E, Agashivala N, Abouzaid S, Weinstock-Guttman B J Neurol Sci. 2013 May 3. PMID: 23647840. Abstract Neural networks to identify multiple sclerosis with optical coherence tomography. Garcia-Martin E, Pablo LE, Herrero R, Ara JR, Martin J, Larrosa JM, Polo V, Garcia-Feijoo J, Fernandez J Acta Ophthalmol. 2013 May 7. PMID: 23647619. Abstract Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design. Cascione M, Wynn D, Barbato LM, Pestreich L, Schofield L, McCague K J Med Econ. 2013 May 20. PMID: 23647445. Abstract Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report. Maciejek Z, Wójcik-Drączkowska H, Wawrzyniak S, Niezgodzińska-Maciejek A Neurol Neurochir Pol. 2013; 47(2):145-151. PMID: 23650003. Abstract Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study. Kubicka K, Pierzchała K Neurol Neurochir Pol. 2013; 47(2):126-130. PMID: 23650000. Abstract Month of birth and risk of multiple sclerosis in a Portuguese population. Barros P, de Sá J M, Sá M J Clin Neurol Neurosurg. 2013 Apr 30. PMID: 23643141. Abstract Animal assisted interventions in neurorehabilitation: A review of the most recent literature. Muñoz Lasa S, Máximo Bocanegra N, Valero Alcaide R, Atín Arratibel MA, Varela Donoso E, Ferriero G Neurologia. 2013 Apr 30. PMID: 23642347. Abstract Clinical applications of diffusion imaging in the spine. Tanenbaum LN Magn Reson Imaging Clin N Am. 2013 May; 21(2):299-320. PMID: 23642555. Abstract Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis. Bester M, Lazar M, Petracca M, Babb JS, Herbert J, Grossman RI, Inglese M J Neurol Sci. 2013 May 1. PMID: 23643443. Abstract Mechanics in Neuronal Development and Repair. Franze K, Janmey PA, Guck J Annu Rev Biomed Eng. 2013 May 3. PMID: 23642242. Abstract Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient. Piscolla E, Hakiki B, Pastò L, Razzolini L, Portaccio E, Amato MP J Neurol. 2013 May 5. PMID: 23645219. Abstract Mechanisms of Immune Modulation By Mesenchymal Stromal Cells and Clinical Translation. Stagg J, Galipeau J Curr Mol Med. 2013 May 2. PMID: 23642066. Abstract Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome. Tenorio-Laranga J, Peltonen I, Keskitalo S, Duran-Torres G, Natarajan R, Männistö PT, Nurmi A, Vartiainen N, Airas L, Elovaara I, et al. Biochem Pharmacol. 2013 Apr 30. PMID: 23643808. Abstract Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats. Salvati S, Di Biase A, Attorri L, Di Benedetto R, Sanchez M, Lorenzini L, Alessandri M, Calzà L J Nutr Biochem. 2013 May 1. PMID: 23642735. Abstract Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand. Mulligan H, Treharne GJ, Hale LA, Smith C J Neurol Phys Ther. 2013 May 2. PMID: 23645142. Abstract Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases. García-Merino A, Fernández O, Montalbán X, de Andrés C, Oreja-Guevara C, Rodríguez-Antigüedad A, Arbizu T Neurologia. 2013 May 2. PMID: 23643683. Abstract The over time development of chronic illness self-management patterns: a longitudinal qualitative study. Audulv A BMC Public Health. 2013; 13:452. Epub 2013 May 07. PMID: 23647658. Abstract Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients. Serpero LD, Filaci G, Parodi A, Battaglia F, Kalli F, Brogi D, Mancardi G L, Uccelli A, Fenoglio D J Neuroimmune Pharmacol. 2013 May 7. Epub 2013 May 07. PMID: 23649711. Abstract Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain. Sanchez-de la Rosa R, Sabater E, Casado MA Health Econ Rev. 2013 May 7; 3(1):13. Epub 2013 May 07. PMID: 23647721. Abstract Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models. Wang X, Ma C, Wu J, Zhu J J Neurosci Res. 2013 Jul; 91(7):871-81. Epub 2013 May 07. PMID: 23653308. Abstract An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer. Mathew A, Pakan JMP, Collin EC, Wang W, McDermott KW, Fitzgerald U, Reynolds R, Pandit AS Biomaterials. 2013 Jul; 34(23):5872-82. Epub 2013 May 06. PMID: 23660252. Abstract Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies. Lunny C, Knopp-Sihota JA, Fraser SN BMC Neurol. 2013; 13:41. Epub 2013 May 06. PMID: 23648120. Abstract Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis. Malfitano A M, Laezza C, D'Alessandro A, Procaccini C, Saccomanni G, Tuccinardi T, Manera C, Macchia M, Matarese G, Gazzerro P, et al. PLoS One. 2013; 8(5):e62511. Epub 2013 May 01. PMID: 23658734. Abstract Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair. Sabo JK, Aumann TD, Kilpatrick TJ, Cate HS PLoS One. 2013; 8(5):e63415. Epub 2013 May 01. PMID: 23650566. Abstract Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients. López-Gómez C, Pino-Ángeles A, Orpez-Zafra T, Pinto-Medel M J, Oliver-Martos B, Ortega-Pinazo J, Arnáiz C, Guijarro-Castro C, Varadé J, Alvarez-Lafuente R, et al. PLoS One. 2013; 8(4):e62540. Epub 2013 Apr 29. PMID: 23658636. Abstract Targeting Potassium Channels Kv1.3 and KC a 3.1: Routes to Selective Immunomodulators in Autoimmune Disorder Treatment? Wang J, Xiang M Pharmacotherapy. 2013 May; 33(5):515-28. Epub 2013 Apr 05. PMID: 23649812. Abstract Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US. Jara M, Barker G, Henney HR Neuropsychiatr Dis Treat. 2013; 9:365-70. Epub 2013 Mar 10. PMID: 23662056. Abstract Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis. Fernández O J Cent Nerv Syst Dis. 2012; 4:117-33. Epub 2012 Aug 29. PMID: 23650472. Abstract New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come. Nicholas J, Morgan-Followell B, Pitt D, Racke MK, Boster A J Cent Nerv Syst Dis. 2012; 4:81-103. Epub 2012 May 16. PMID: 23650470. Abstract Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder. Yaguchi H, Sakushima K, Takahashi I, Nishimura H, Yashima-Yamada M, Nakamura M, Tsuzaka K, Maruo Y, Takahashi T, Yabe I, et al. Intern Med. 2013; 52(9):969-72. Epub 2012 Mar 01. PMID: 23648715. Abstract Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine. Schreiner TL, Miravalle A J Cent Nerv Syst Dis. 2012; 4:1-14. Epub 2012 Jan 03. PMID: 23650463. Abstract Autonomic dysfunction in multiple sclerosis. Al-Araji AH, Al-Mahdawi AM, Mohammad AI Neurosciences (Riyadh). 2003 Jul; 8(3):177-83. PMID: 23649115. Abstract
Editors' Pick Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity. Marignier R, Bernard-Valnet R, Giraudon P, Collongues N, Papeix C, Zéphir H, Cavillon G, Rogemond V, Casey R, Frangoulis B, et al. Neurology. 2013 May 8. PMID: 23658379. Abstract
Editors' Pick Incidence of multiple sclerosis in multiple racial and ethnic groups. Langer-Gould A, Brara SM, Beaber BE, Zhang JL Neurology. 2013 May 7; 80(19):1734-9. Epub 1969 Dec 31. PMID: 23650231. Abstract
Editors' Pick Activated microglia enhance neurogenesis via trypsinogen secretion. Nikolakopoulou AM, Dutta R, Chen Z, Miller RH, Trapp BD Proc Natl Acad Sci U S A. 2013 May 6. PMID: 23650361. Abstract
Editors' Pick Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Rafalski VA, Ho PP, Brett JO, Ucar D, Dugas JC, Pollina EA, Chow LML, Ibrahim A, Baker SJ, Barres BA, et al. Nat Cell Biol. 2013 May 5; 15(6):614-624. Epub 2013 May 05. PMID: 23644469. Abstract
Coenzyme Q10 Supplementation Reduces Oxidative Stress and Increases Antioxidant Enzyme Activity in Patients with Relapsing-Remitting Multiple Sclerosis. Sanoobar M, Eghtesadi S, Azimi A R, Khalili M, Jazayeri S, Gohari M R Int J Neurosci. 2013 May 10. PMID: 23659338. Abstract
Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis. Bouafia A, Golmard J-L, Thuries V, Sazdovitch V, Duyckaerts C, Hauw JJ, Fontaine B, Seilhean D Neuropathol Appl Neurobiol. 2013 May 10. PMID: 23659577. Abstract
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis. Nielsen N M, Jørgensen KT, Bager P, Stenager E, Pedersen BV, Hjalgrim H, Koch-Henriksen N, Frisch M Am J Epidemiol. 2013 May 9. PMID: 23660795. Abstract
Pertussis toxin attenuates experimental autoimmune encephalomyelitis by upregulating neuronal vascular endothelial growth factor. Tang Z, Yin J-X, Han P, Gan Y, Coons SW, Wang C, Maalouf M, Shi J Neuroreport. 2013 Jun 19; 24(9):469-75. PMID: 23660634. Abstract
Multiple sclerosis lymphocytes upregulate A2A adenosine receptors which are anti-inflammatory when stimulated. Vincenzi F, Corciulo C, Targa M, Merighi S, Gessi S, Casetta I, Gentile M, Granieri E, Borea P A, Varani K Eur J Immunol. 2013 May 10. PMID: 23661562. Abstract
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges. Fujihara K, Leite M I Neurology. 2013 May 8. PMID: 23658387. Abstract
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: No. Tur C, Montalban X Mult Scler. 2013 May; 19(6):717-8. PMID: 23658236. Abstract
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: Commentary. Hutchinson M Mult Scler. 2013 May; 19(6):719-20. PMID: 23658237. Abstract
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores. Zagaglia S, Balestrini S, Perticaroli E, Danni MC, Luzzi S, Silvestrini M, Provinciali L Neurol Sci. 2013 May 10. Epub 2013 May 10. PMID: 23660636. Abstract
The Immune Pathogenesis of Multiple Sclerosis. Weissert R J Neuroimmune Pharmacol. 2013 May 10. Epub 2013 May 10. PMID: 23660832. Abstract
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival. Medina-Rodríguez EM, Arenzana FJ, Pastor J, Redondo M, Palomo V, García de Sola R, Gil C, Martínez A, Bribián A, de Castro F Cell Mol Life Sci. 2013 May 10. Epub 2013 May 10. PMID: 23661015. Abstract
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How? Edan G, Lepage E CNS Drugs. 2013 May 9. PMID: 23657788. Abstract
Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5. Rahgozar K, Wright E, Carrithers LM, Carrithers MD J Neuropathol Exp Neurol. 2013 Jun; 72(6):489-504. PMID: 23656992. Abstract
Multiple sclerosis: autoimmunity and viruses. Cusick MF, Libbey JE, Fujinami RS Curr Opin Rheumatol. 2013 May 7. PMID: 23656710. Abstract
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells. Møller-Larsen A, Brudek T, Petersen T, Petersen E L, Aagaard M, Hansen D T, Christensen T Clin Exp Immunol. 2013 May 9. PMID: 23656307. Abstract
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes. Sandberg-Wollheim M, Olsson T Mult Scler. 2013 May; 19(6):714-6. PMID: 23658235. Abstract
Evoked potential tests in clinical diagnosis. Sand T, Kvaløy M B, Wader T, Hovdal H Tidsskr Nor Laegeforen. 2013 May 7; 133(9):960-965. PMID: 23652144. Abstract
Demographic and clinical factors associated with changes in employment in multiple sclerosis. Moore P, Harding KE, Clarkson H, Pickersgill TP, Wardle M, Robertson NP Mult Scler. 2013 May 7. PMID: 23652213. Abstract
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study. Tinghög P, Hillert J, Kjeldgård L, Wiberg M, Glaser A, Alexanderson K Mult Scler. 2013 May 7. PMID: 23652218. Abstract
Clinical impact of early brain atrophy in clinically isolated syndromes. Pérez-Miralles F, Sastre-Garriga J, Tintoré M, Arrambide G, Nos C, Perkal H, Río J, Edo M, Horga A, Castilló J, et al. Mult Scler. 2013 May 7. PMID: 23652215. Abstract
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis. Lapshin H, Lanctôt KL, O'Connor P, Feinstein A Mult Scler. 2013 May 7. PMID: 23652217. Abstract
The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study. Lacy M, Hauser M, Pliskin N, Assuras S, Valentine MO, Reder A Mult Scler. 2013 May 7. PMID: 23652214. Abstract
The economic impact of multiple sclerosis in Australia in 2010. Palmer AJ, Colman S, O'Leary B, Taylor BV, Simmons RD Mult Scler. 2013 May 7. PMID: 23652216. Abstract
Elevated CSF histamine levels in multiple sclerosis patients. Kallweit U, Aritake K, Bassetti CL, Blumenthal S, Hayaishi O, Linnebank M, Baumann CR, Urade Y Fluids Barriers CNS. 2013 May 9; 10(1):19. Epub 2013 May 09. PMID: 23659456. Abstract
Clinical and pathological features of acute optic neuritis in Chinese patients. Zhang J-Y, Shen X-Z, Sun L, Lu Z-Z, Ye W Chin Med J (Engl). 2013 May; 126(9):1689-92. PMID: 23652052. Abstract
Upregulation of ciliary neurotrophic factor in astrocytes by aspirin: Implications for remyelination in multiple sclerosis. Modi KK, Sendtner M, Pahan K J Biol Chem. 2013 May 7. PMID: 23653362. Abstract
A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis. Yusuf A, Koski L J Neurol Sci. 2013 May 4. PMID: 23651867. Abstract
The perceptions of people with multiple sclerosis about the NHS provision of physiotherapy services. Markwick R, Singleton C, Conduit J Disabil Rehabil. 2013 May 7. PMID: 23651127. Abstract
Month of birth in multiple sclerosis with and without longitudinally extensive spinal cord lesions: A study of a Japanese national survey. Araki Y, Kinoshita M, Motoyama R, Matsushita T, Nakagawa M, Kira J-I, Tanaka M J Neurol Sci. 2013 May 4. PMID: 23651868. Abstract
Metallic gold beads in hyaluronic acid: a novel form of gold-based immunosuppression? Investigations of the immunosuppressive effects of metallic gold on cultured J774 macrophages and on neuronal gene expression in experimental autoimmune encephalomyeliti Pedersen D S, Tran T P, Smidt K, Bibby B M, Rungby J, Larsen A Biometals. 2013 May 8. Epub 2013 May 08. PMID: 23653168. Abstract
Adherence Associated with Oral Medications in the Treatment of Spasticity. Halpern R, Gillard P, Graham GD, Varon SF, Zorowitz RD PM R. 2013 May 3. PMID: 23648652. Abstract
Tadeusz Markiewicz - the researcher's profile and his role in the studies on neuromyelitis optica. Michalak S Neurol Neurochir Pol. 2013; 47(2):194-198. PMID: 23650011. Abstract
Effects of whole-body vibration training on physical function in patients with Multiple Sclerosis. Hilgers C, Mündermann A, Riehle H, Dettmers C NeuroRehabilitation. 2013 Jan 1; 32(3):655-63. PMID: 23648620. Abstract
Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. Tanaka T, Murakami K, Bando Y, Yoshida S J Neurochem. 2013 May 7. PMID: 23647102. Abstract
Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Gelfand JM, Green AJ Brain. 2013 Feb 8. PMID: 23650224. Abstract
Direct and indirect cost burden associated with multiple sclerosis relapses: Excess costs of persons with MS and their spouse caregivers. Parisé H, Laliberté F, Lefebvre P, Duh M S, Kim E, Agashivala N, Abouzaid S, Weinstock-Guttman B J Neurol Sci. 2013 May 3. PMID: 23647840. Abstract
Neural networks to identify multiple sclerosis with optical coherence tomography. Garcia-Martin E, Pablo LE, Herrero R, Ara JR, Martin J, Larrosa JM, Polo V, Garcia-Feijoo J, Fernandez J Acta Ophthalmol. 2013 May 7. PMID: 23647619. Abstract
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design. Cascione M, Wynn D, Barbato LM, Pestreich L, Schofield L, McCague K J Med Econ. 2013 May 20. PMID: 23647445. Abstract
Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report. Maciejek Z, Wójcik-Drączkowska H, Wawrzyniak S, Niezgodzińska-Maciejek A Neurol Neurochir Pol. 2013; 47(2):145-151. PMID: 23650003. Abstract
Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study. Kubicka K, Pierzchała K Neurol Neurochir Pol. 2013; 47(2):126-130. PMID: 23650000. Abstract
Month of birth and risk of multiple sclerosis in a Portuguese population. Barros P, de Sá J M, Sá M J Clin Neurol Neurosurg. 2013 Apr 30. PMID: 23643141. Abstract
Animal assisted interventions in neurorehabilitation: A review of the most recent literature. Muñoz Lasa S, Máximo Bocanegra N, Valero Alcaide R, Atín Arratibel MA, Varela Donoso E, Ferriero G Neurologia. 2013 Apr 30. PMID: 23642347. Abstract
Clinical applications of diffusion imaging in the spine. Tanenbaum LN Magn Reson Imaging Clin N Am. 2013 May; 21(2):299-320. PMID: 23642555. Abstract
Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis. Bester M, Lazar M, Petracca M, Babb JS, Herbert J, Grossman RI, Inglese M J Neurol Sci. 2013 May 1. PMID: 23643443. Abstract
Mechanics in Neuronal Development and Repair. Franze K, Janmey PA, Guck J Annu Rev Biomed Eng. 2013 May 3. PMID: 23642242. Abstract
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient. Piscolla E, Hakiki B, Pastò L, Razzolini L, Portaccio E, Amato MP J Neurol. 2013 May 5. PMID: 23645219. Abstract
Mechanisms of Immune Modulation By Mesenchymal Stromal Cells and Clinical Translation. Stagg J, Galipeau J Curr Mol Med. 2013 May 2. PMID: 23642066. Abstract
Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome. Tenorio-Laranga J, Peltonen I, Keskitalo S, Duran-Torres G, Natarajan R, Männistö PT, Nurmi A, Vartiainen N, Airas L, Elovaara I, et al. Biochem Pharmacol. 2013 Apr 30. PMID: 23643808. Abstract
Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats. Salvati S, Di Biase A, Attorri L, Di Benedetto R, Sanchez M, Lorenzini L, Alessandri M, Calzà L J Nutr Biochem. 2013 May 1. PMID: 23642735. Abstract
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand. Mulligan H, Treharne GJ, Hale LA, Smith C J Neurol Phys Ther. 2013 May 2. PMID: 23645142. Abstract
Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases. García-Merino A, Fernández O, Montalbán X, de Andrés C, Oreja-Guevara C, Rodríguez-Antigüedad A, Arbizu T Neurologia. 2013 May 2. PMID: 23643683. Abstract
The over time development of chronic illness self-management patterns: a longitudinal qualitative study. Audulv A BMC Public Health. 2013; 13:452. Epub 2013 May 07. PMID: 23647658. Abstract
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients. Serpero LD, Filaci G, Parodi A, Battaglia F, Kalli F, Brogi D, Mancardi G L, Uccelli A, Fenoglio D J Neuroimmune Pharmacol. 2013 May 7. Epub 2013 May 07. PMID: 23649711. Abstract
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain. Sanchez-de la Rosa R, Sabater E, Casado MA Health Econ Rev. 2013 May 7; 3(1):13. Epub 2013 May 07. PMID: 23647721. Abstract
Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models. Wang X, Ma C, Wu J, Zhu J J Neurosci Res. 2013 Jul; 91(7):871-81. Epub 2013 May 07. PMID: 23653308. Abstract
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer. Mathew A, Pakan JMP, Collin EC, Wang W, McDermott KW, Fitzgerald U, Reynolds R, Pandit AS Biomaterials. 2013 Jul; 34(23):5872-82. Epub 2013 May 06. PMID: 23660252. Abstract
Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies. Lunny C, Knopp-Sihota JA, Fraser SN BMC Neurol. 2013; 13:41. Epub 2013 May 06. PMID: 23648120. Abstract
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis. Malfitano A M, Laezza C, D'Alessandro A, Procaccini C, Saccomanni G, Tuccinardi T, Manera C, Macchia M, Matarese G, Gazzerro P, et al. PLoS One. 2013; 8(5):e62511. Epub 2013 May 01. PMID: 23658734. Abstract
Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair. Sabo JK, Aumann TD, Kilpatrick TJ, Cate HS PLoS One. 2013; 8(5):e63415. Epub 2013 May 01. PMID: 23650566. Abstract
Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients. López-Gómez C, Pino-Ángeles A, Orpez-Zafra T, Pinto-Medel M J, Oliver-Martos B, Ortega-Pinazo J, Arnáiz C, Guijarro-Castro C, Varadé J, Alvarez-Lafuente R, et al. PLoS One. 2013; 8(4):e62540. Epub 2013 Apr 29. PMID: 23658636. Abstract
Targeting Potassium Channels Kv1.3 and KC a 3.1: Routes to Selective Immunomodulators in Autoimmune Disorder Treatment? Wang J, Xiang M Pharmacotherapy. 2013 May; 33(5):515-28. Epub 2013 Apr 05. PMID: 23649812. Abstract
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US. Jara M, Barker G, Henney HR Neuropsychiatr Dis Treat. 2013; 9:365-70. Epub 2013 Mar 10. PMID: 23662056. Abstract
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis. Fernández O J Cent Nerv Syst Dis. 2012; 4:117-33. Epub 2012 Aug 29. PMID: 23650472. Abstract
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come. Nicholas J, Morgan-Followell B, Pitt D, Racke MK, Boster A J Cent Nerv Syst Dis. 2012; 4:81-103. Epub 2012 May 16. PMID: 23650470. Abstract
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder. Yaguchi H, Sakushima K, Takahashi I, Nishimura H, Yashima-Yamada M, Nakamura M, Tsuzaka K, Maruo Y, Takahashi T, Yabe I, et al. Intern Med. 2013; 52(9):969-72. Epub 2012 Mar 01. PMID: 23648715. Abstract
Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine. Schreiner TL, Miravalle A J Cent Nerv Syst Dis. 2012; 4:1-14. Epub 2012 Jan 03. PMID: 23650463. Abstract
Autonomic dysfunction in multiple sclerosis. Al-Araji AH, Al-Mahdawi AM, Mohammad AI Neurosciences (Riyadh). 2003 Jul; 8(3):177-83. PMID: 23649115. Abstract